Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 3/2014

01.06.2014 | Original Article

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

verfasst von: Sudha Prasad, Yogesh Kumar, Megha Singhal, Shashi Sharma

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate role of serum estradiol levels in predicting likelihood of pregnancy in women undergoing GnRH-a protocol in IVF-ET cycles.

Design

A 3-year retrospective analysis of estradiol levels on down-regulated day 2, day 6, and day of hCG trigger and subsequent clinical pregnancy rates.

Setting

A university hospital tertiary referral centre.

Population or Sample

Women undergoing IVF treatment.

Methods

Hormonal assessment on the down-regulated day 2, day 6, and day of hCG trigger.

Main Outcome Measure(s)

Comparison of hormonal profile, antral follicular count on day 2, endometrial thickness on day of trigger, and number of oocytes retrieved between pregnant and the non-pregnant group. The prediction of IVF success was based on the quantitative levels of estradiol on a specific day in down-regulated cycle.

Result(s)

The overall pregnancy rate was 32.25 % (50/160). Estradiol level on down-regulated day 2 was 31.9 ± 12.6 and on the day of trigger was 1,996.46 ± 1,252.36 in pregnant women, which was significantly higher as compared to estradiol levels in non-pregnant women (27.6 ± 12.3 and 1,525.1 ± 1,116.42, respectively). It was found to be a significant prognostic marker for successful IVF treatment. Estradiol levels on down-regulated day 6 were found to be non-significant between the two groups.

Conclusion(s)

Estradiol level on down-regulated day 2 of menstrual cycle and on the day of trigger was found to have a significant impact on the success of IVF-ET.
Literatur
2.
Zurück zum Zitat 2009 Assisted Reproductive Technology, Success Rates, National Summary and Fertility Clinic Reports. National Centers for Chronic Disease Prevention and Health Promotion, 2011. 2009 Assisted Reproductive Technology, Success Rates, National Summary and Fertility Clinic Reports. National Centers for Chronic Disease Prevention and Health Promotion, 2011.
3.
Zurück zum Zitat Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;4:651–4. Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;4:651–4.
4.
Zurück zum Zitat Licciardi FL, Liu HC, Rosemwaks Z et al. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;5:991–4. Licciardi FL, Liu HC, Rosemwaks Z et al. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;5:991–4.
5.
Zurück zum Zitat Yanushpolsky EH, Hurwitz S, Tikh E. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization in women younger than 40 years of age. Fertil Steril. 2003;1:111–5.CrossRef Yanushpolsky EH, Hurwitz S, Tikh E. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization in women younger than 40 years of age. Fertil Steril. 2003;1:111–5.CrossRef
6.
Zurück zum Zitat Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: The physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 1998;3:474–7.CrossRef Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: The physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 1998;3:474–7.CrossRef
7.
Zurück zum Zitat Tomas C, Nuojua-Huttunen S, Martinaken H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in vitro fertilization. Hum Reprod. 1997;2:220–3.CrossRef Tomas C, Nuojua-Huttunen S, Martinaken H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in vitro fertilization. Hum Reprod. 1997;2:220–3.CrossRef
8.
Zurück zum Zitat Hendriks DJ, Mol BW, Bancsi LF et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;2:291–301.CrossRef Hendriks DJ, Mol BW, Bancsi LF et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;2:291–301.CrossRef
9.
Zurück zum Zitat Ficicioglu C, Kutlu T, Baglam E, et al. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;3:592–6.CrossRef Ficicioglu C, Kutlu T, Baglam E, et al. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;3:592–6.CrossRef
10.
Zurück zum Zitat Hull MG, Fleming CF, Hughes AO, et al. The age related decline in female fecundity: a quantitative controlled study of implanting capacity and survical of individual embryos after in vitro fertilization. Fertil Steril. 1996;4:783–90. Hull MG, Fleming CF, Hughes AO, et al. The age related decline in female fecundity: a quantitative controlled study of implanting capacity and survical of individual embryos after in vitro fertilization. Fertil Steril. 1996;4:783–90.
11.
Zurück zum Zitat Scott RT, Hofmann GE, Oehninger S, et al. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril. 1990;2:297–302. Scott RT, Hofmann GE, Oehninger S, et al. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril. 1990;2:297–302.
12.
Zurück zum Zitat Ocal P, Aydin S, Cepni J, et al. Follicular fluid concentrations of vascular endothelial growthfactor, inhibin A, inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2004;2:194–9.CrossRef Ocal P, Aydin S, Cepni J, et al. Follicular fluid concentrations of vascular endothelial growthfactor, inhibin A, inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2004;2:194–9.CrossRef
13.
Zurück zum Zitat Khalaf Y, Taylor A, Braude P. Low serum E2 concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertil Steril. 2000;74:63–6.PubMedCrossRef Khalaf Y, Taylor A, Braude P. Low serum E2 concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertil Steril. 2000;74:63–6.PubMedCrossRef
14.
Zurück zum Zitat Devroey P, Bourrgain C, Macklon NS, et al. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15:84–90.PubMedCrossRef Devroey P, Bourrgain C, Macklon NS, et al. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15:84–90.PubMedCrossRef
15.
Zurück zum Zitat Anifandis G, Koutselini E, Louridas K, et al. Estradiol and leptin as conditional prognostic IVF markers. Reproduction. 2005;129:531–4.PubMedCrossRef Anifandis G, Koutselini E, Louridas K, et al. Estradiol and leptin as conditional prognostic IVF markers. Reproduction. 2005;129:531–4.PubMedCrossRef
16.
Zurück zum Zitat Papageorgiou T, Guibert J, Goffinet F et al. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod. 2002;17:2846–50.PubMedCrossRef Papageorgiou T, Guibert J, Goffinet F et al. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod. 2002;17:2846–50.PubMedCrossRef
17.
Zurück zum Zitat Speroff L, Glass RH, Kase AG. Regulation of menstrual cycle. Clinical gynecologic endocrinology and infertility. Maryland: Williams & Wilkins; 1994. p. 141–83. Speroff L, Glass RH, Kase AG. Regulation of menstrual cycle. Clinical gynecologic endocrinology and infertility. Maryland: Williams & Wilkins; 1994. p. 141–83.
18.
Zurück zum Zitat Tesarik J, Mendoza C. Nongenomic. Effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab. 1995;80:1438–43.PubMed Tesarik J, Mendoza C. Nongenomic. Effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab. 1995;80:1438–43.PubMed
19.
Zurück zum Zitat Weghofer A, Margreiter M, Fauster Y et al. Age-specific FSH levels as a tool for appropriate patient counseling in assisted reproduction. Hum Reprod. 2005;20(9):2448–52.PubMedCrossRef Weghofer A, Margreiter M, Fauster Y et al. Age-specific FSH levels as a tool for appropriate patient counseling in assisted reproduction. Hum Reprod. 2005;20(9):2448–52.PubMedCrossRef
20.
Zurück zum Zitat Coroleu B, Barri PN, Carreras O et al. The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study. Hum Reprod. 2002;17(2):341–6.PubMedCrossRef Coroleu B, Barri PN, Carreras O et al. The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study. Hum Reprod. 2002;17(2):341–6.PubMedCrossRef
21.
Zurück zum Zitat Tomas C, Tikkinen K, Tuomivaara L et al. The degree of difficulty of embryo transfer is an independent factor for predicting pregnancy. Hum Reprod. 2002;17(10):2632–5.PubMedCrossRef Tomas C, Tikkinen K, Tuomivaara L et al. The degree of difficulty of embryo transfer is an independent factor for predicting pregnancy. Hum Reprod. 2002;17(10):2632–5.PubMedCrossRef
23.
Zurück zum Zitat Makker A, Singh MM. Endometrial receptivity: clinical assessment in relation to fertility, infertility, and antifertility. Med Res Rev. 2006;26(6):699–746.PubMedCrossRef Makker A, Singh MM. Endometrial receptivity: clinical assessment in relation to fertility, infertility, and antifertility. Med Res Rev. 2006;26(6):699–746.PubMedCrossRef
Metadaten
Titel
Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
verfasst von
Sudha Prasad
Yogesh Kumar
Megha Singhal
Shashi Sharma
Publikationsdatum
01.06.2014
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 3/2014
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-014-0515-6

Weitere Artikel der Ausgabe 3/2014

The Journal of Obstetrics and Gynecology of India 3/2014 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.